Study guide
2.3 Federal CS Prescription Rules (CII–CV)
Minnesota MPJE Pharmacy Jurisprudence
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the Minnesota MPJE 1.2 NABP Competency Areas & Weights 1.3 How to Use This Guide & Study Strategy
2 Federal Controlled Substances Foundations
2.1 CSA Schedules I–V & MN Alignment 2.2 DEA Registration, Forms 222/106/41 & Security 2.3 Federal CS Prescription Rules (CII–CV) 2.4 Inventories, Recordkeeping & Theft/Loss
3 Federal Drug Regulation, Privacy & Supply Chain
3.1 FD&C Act, Legend vs OTC, Misbranding & Adulteration 3.2 OBRA '90, Medicaid DUR & Federal Counseling Floor 3.3 HIPAA Privacy for Pharmacy 3.4 DSCSA & Drug Supply Chain Integrity
4 MN Board, Licensure & Eligibility
4.1 Minnesota Board of Pharmacy Authority & Sources of Law 4.2 Pharmacist Licensure by Exam & Score Transfer 4.3 License Transfer (Reciprocity) & Background Checks 4.4 Interns, Preceptors & 1,600-Hour Experience
5 Renewal, CE, PIC & Discipline
5.1 License Renewal & 30-Hour Biennial CE 5.2 Pharmacist-in-Charge Duties 5.3 Discipline & Unprofessional Conduct 5.4 HPSP, Impaired Practitioners & Mandatory Reporting
6 Technicians, Interns & Supervision
6.1 Technician Registration, Training & CE 6.2 Supervision Ratios (Statute 151.102 & Rule 6800.3850) 6.3 Intern Scope, Delegation & Certification of Accuracy
7 Prescription Authority & Validity
7.1 Who May Prescribe in Minnesota 7.2 Prescription Content & Validity Requirements 7.3 Controlled Substance Prescribing (Chapter 152 + Federal) 7.4 Refills, Partial Fills & Quantity Limits
8 Advanced MN Pharmacist Practice
8.1 Collaborative Practice Agreements & Medication Therapy Management 8.2 Pharmacist Prescriptive Authority (Minn. Stat. 151.37) 8.3 Immunizations & Vaccine Administration 8.4 Drug Administration & Therapy Management
9 Counseling, DUR & Patient Safety
9.1 Patient Counseling Requirements (Rule 6800.0910) 9.2 Prospective Drug Utilization Review 9.3 Returning & Reusing Drugs (Rule 6800.2700)
10 MN PMP & Opioid Public-Health Laws
10.1 Minnesota PMP Overview, Reporting & Pharmacist Use 10.2 Naloxone Access, Steve’s Law & Opioid Antagonists 10.3 Legitimate Medical Purpose & Red Flags
11 Dispensing: Transfers, Labels & Substitution
11.1 Prescription Transfers Between Pharmacies 11.2 Labeling & Packaging of Dispensed Drugs 11.3 Generic Substitution & Product Selection 11.4 Emergency Dispensing, OTC/BTC & Pseudoephedrine
12 Pharmacy Operations & Facilities
12.1 Pharmacy Permits, Classifications & Inspections 12.2 Security, Delivery & Work Conditions 12.3 Operational Recordkeeping & Inventories 12.4 Central Fill, Centralized Processing & Automation
13 Compounding & Hazardous Drugs
13.1 Sterile, Nonsterile & Hazardous Compounding 13.2 Minnesota Compounding Rules & Beyond-Use Dates
14 Test-Day Strategy & Final Review
14.1 When Minnesota Law Is Stricter Than Federal Law 14.2 Test-Day Strategy & Common Traps
2.3 Federal CS Prescription Rules (CII–CV)
Key Takeaways Explain This Topic AI
A valid controlled-substance prescription requires a legitimate medical purpose, a practitioner acting in the usual course of professional practice, and required content elements including patient, drug, directions, and prescriber identity/DEA data
Schedule II prescriptions may not be refilled; limited emergency oral CII dispensing is allowed only with tight follow-up rules
CII partial fills follow distinct tracks: traditional incomplete-fill timing, CARA patient/prescriber-requested partials within 30 days of issue, and longer windows for LTCF or terminally ill patients
Schedule III and IV prescriptions are limited to five refills within six months of the issue date under federal law
Electronic prescribing of controlled substances (EPCS) is federally permitted when systems meet identity-proofing and two-factor authentication requirements; Minnesota may still impose stricter practice expectations
Last updated: July 2026
2.3 Federal CS Prescription Rules (CII–CV)
Quick Answer: Controlled-substance prescriptions are valid only for a legitimate medical purpose in the usual course of professional practice , with required prescription data. CII: no refills ; partial fills follow special timing rules (including traditional incomplete-fill rules and CARA patient/prescriber partials with remaining quantity due within 30 days of issue). CIII–CIV: up to 5 refills within 6 months. EPCS is allowed when systems meet federal security standards. Always layer Minnesota stricter rules and PMP expectations on top.
This section is the federal “how prescriptions work” engine for controlled drugs. Minnesota-specific who-may-prescribe details appear later; here you master the federal skeleton the MPJE still tests constantly.
Validity Floor: Purpose + Course of Practice + Data Elements
Before schedule-specific refill math, every CS prescription must clear three gates:
- Legitimate medical purpose
- Issued by a practitioner acting in the usual course of professional practice
Contains the required information and is in an allowed format (written, electronic under EPCS, or oral when permitted)
Core federal content expectations typically include:
- Patient’s full name and address
- Drug name, strength, dosage form, quantity, and directions for use
- Prescriber’s name, address, and DEA registration number
- Date issued and signature (or compliant electronic signature for EPCS)
- Number of refills authorized when refills are permitted (CIII–CV)
Missing critical elements is not a minor clerical nit—depending on the defect, the prescription may be invalid until corrected under allowed procedures. Corresponding responsibility means pharmacists should not “fix it later” for a high-risk CII when the order is facially incomplete or suspicious.
- Schedule II Prescription Rules
- No refills
Federally, Schedule II prescriptions cannot be refilled. A new prescription is required for each fill cycle (with limited special structures such as multiple prescriptions issued on the same day for sequential filling).
Multiple CII prescriptions on the same day (90-day construct)
A practitioner may issue multiple CII prescriptions on the same day for the same patient and drug, written so that:
The total does not exceed a 90-day supply, and
Each prescription (other than the first) includes earliest fill instructions such as “do not fill before [date]”
- Each is a valid separate prescription meeting all requirements
- Doing so is permissible under applicable law and is appropriate for the patient
This is not a refill. It is a series of new prescriptions with deferred fill dates. Exam writers love to bait “refill” language here—reject that wording.
Emergency oral CII
In a true emergency , a pharmacist may dispense a CII pursuant to an oral authorization when:
- Immediate administration is necessary
- No appropriate alternative treatment is available
- It is not reasonably possible for the prescriber to provide a written/electronic prescription at that moment
Critical limits:
Dispense only the quantity needed to cover the emergency period
The prescriber must deliver a written/signed (or compliant electronic) prescription to the pharmacy within 7 days covering that emergency quantity
If the follow-up prescription does not arrive, the pharmacist must notify the DEA (exam classic)
“Emergency” is clinical and situational—not “the patient forgot to call earlier and wants a full month tonight.”
Electronic CII (EPCS)
Federal rules allow electronic prescriptions for controlled substances when both the prescriber’s system and the pharmacy’s system are EPCS-compliant. Core ideas:
- Identity proofing of the prescriber
- Two-factor authentication when signing
- Secure transmission and audit trails
- Pharmacy ability to receive and archive the electronic record without improper alteration
A printout of an email is not automatically a valid CII prescription. If the stem says “EPCS-compliant electronic prescription,” treat it as an allowed CII format. If the stem describes a casual PDF texted to the patient, be skeptical.
Faxed CII prescriptions
As a general federal rule, a fax is not a substitute for the original written CII prescription before dispensing, with important exceptions often tested at a high level (for example, certain long-term care, hospice, or injectable compounding situations where federal rules allow the fax to serve as the original). For community-pharmacy defaults, expect original written or EPCS—not “fax is always fine for oxycodone.”
CII Partial Fills: Three Tracks You Must Separate
Partial fills are a top MPJE failure point because students mash the timelines together.
Track A — Pharmacy cannot supply the full quantity (traditional incomplete fill)
If the pharmacy lacks sufficient stock, it may partially fill a CII and supply the remainder within the traditional short window associated with incomplete pharmacy supply (commonly tested as the 72-hour remainder concept for the unable-to-supply scenario). If the remainder cannot be provided in time, the balance is void and a new prescription is needed. Document the partial quantity dispensed.
Track B — Patient or prescriber requests a partial fill (CARA)
Under the Comprehensive Addiction and Recovery Act (CARA) amendments and implementing rules, a CII prescription may be partially filled when requested by the patient or the prescriber . Key exam points:
The total quantity dispensed across partials cannot exceed the face amount prescribed
The remaining portions must be filled not later than 30 days after the date the prescription was written (issue date)
- After that window, no further partials on that prescription
- This is not a refill mechanism; it is staged dispensing of one prescription’s quantity
CARA partials are about patient/prescriber choice and opioid stewardship—not only about pharmacy stockouts.
Track C — Long-term care facility (LTCF) or terminally ill patients
For patients who are terminally ill or residing in an LTCF , CII partial fills may continue for up to 60 days from the issue date, with meticulous documentation of each partial (date, quantity, remaining amount, pharmacist identification). This longer window recognizes care-setting realities and is not the default for ambulatory retail patients.
Partial-fill decision table
- Situation Typical remainder window tested
- Pharmacy incomplete supply Short traditional window (72-hour concept)
- Patient/prescriber requested partial (CARA) Remainder within 30 days of issue
- LTCF or terminally ill Up to 60 days from issue
Always document remaining quantity and never exceed the prescribed total.
Schedule III and IV: Refills and Time Limits
Federal rule for CIII and CIV prescriptions:
- May be refilled only if authorized on the prescription
- Maximum of 5 refills
- All refills must occur within 6 months of the date of issue
- After 5 refills or 6 months (whichever comes first as a practical limit), a new prescription is required
Oral CIII/CIV prescriptions are generally allowed federally (unlike the default CII written/EPCS model), with the pharmacist promptly reducing the oral order to writing. Transfers of remaining refills for CIII–CV have special one-time transfer rules between pharmacies (state law may be stricter—Minnesota transfer details appear in the dispensing chapter).
Partial filling of CIII–CIV is allowed if each partial is recorded and the total quantity does not exceed the amount prescribed; all partials must still fit within the 6-month life of the prescription.
Schedule V
Schedule V prescriptions may be refilled as authorized by the prescriber. Federally, CV does not automatically inherit the same hard “5 refills / 6 months” ceiling that applies to CIII/CIV, but:
- CV drugs are still controlled substances
- Recordkeeping, labeling, corresponding responsibility, and Minnesota PMP reporting still apply
- State law or pharmacy policy may impose tighter operational limits—use the stem and Minnesota prevailing law
Some CV products historically had limited OTC sale pathways under federal conditions (signature logs, quantity limits, age restrictions). Do not assume every CV is OTC; most exam CV items in modern practice are prescription products such as pregabalin.
Labeling and Dispensing Record Basics (Federal Floor)
When dispensing CS, the pharmacy must create a record linking:
- Prescription details and date filled
- Quantity dispensed
- Pharmacist involvement/initials as required
- Refill history for CIII–CV
Federal labeling expectations for prescription drugs still apply (pharmacy name/address, serial number, patient name, directions, cautionary statements). Controlled substances also carry the federal transfer caution on the label for CII–CIV (“Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed”).
Minnesota Overlay (Even on “Federal” Items)
When answering MN MPJE questions:
Apply federal CII no-refill and CIII/CIV 5/6 rules unless a stricter Minnesota rule changes the outcome
Remember who may prescribe under Minn. Stat. 151.01 / 151.37 is a Minnesota question layered on DEA registration
PMP duties are distinct: account registration and dispenser reporting are statutory; a clinical query is appropriate when required by a specific rule or when red flags and corresponding responsibility make it necessary
- Electronic prescribing mandates or opioid-specific Minnesota limits—if tested—win over looser federal defaults
- Corresponding responsibility is enforced in real Minnesota board scenarios, not only in federal manuals
- Worked Mini-Vignettes
Vignette 1: Written oxycodone prescription issued March 1 for 60 tablets; patient requests 20 now and wants the rest later for safety at home. Under CARA partial-fill logic, the remaining tablets must be dispensed by March 31 (30 days from issue), not six months later, and never as “refills.”
Vignette 2: Alprazolam prescription issued January 10 with “PRN refill” language but no number. Federally, CIII/CIV refills must be authorized; unclear authorization is not a blank check for five refills. Clarify with the prescriber and stay within 5 fills / 6 months.
Vignette 3: Emergency oral morphine for a hospice crisis on a weekend—dispense only emergency quantity, obtain the follow-up prescription within 7 days, and notify DEA if it never arrives.
- Common Traps
- Calling sequential “do not fill before” CII prescriptions “refills”
- Applying the 60-day LTCF partial-fill window to healthy ambulatory patients
- Using the CARA 30-day remainder window as if it were a 6-month refill period
Allowing a sixth refill on a CIV because “the patient still has tablets authorized on the original face amount” after five refills were already dispensed
- Treating EPCS as optional free-text email prescribing
- Ignoring Minnesota stricter practice rules after correctly recalling a federal floor
If you can assign a vignette to the correct schedule and then pick the correct refill/partial-fill track, you will capture a large share of federal CS prescription points on the MN MPJE.